Cdr2L Antibody Market: Onco-Neural Antigen Targeting in...

adicionou um novo artigo Health

2026-07-29 09:40:34 -

Cdr2L Antibody Market: Onco-Neural Antigen Targeting in Paraneoplastic Syndrome Diagnostics

Market Overview The Cdr2L Antibody Market is gaining specialized traction as neuro-oncology and autoimmune neurology converge in the diagnosis of paraneoplastic cerebellar degeneration and related syndromes. Anti-CDR2L (cerebellar degeneration-related protein 2-like) antibodies serve as critical serological biomarkers associated with underlying malignancies—particularly ovarian and breast...

0 Comentários 0 Compartilhamentos 2 Visualizações 0 Anterior